AI Can Accurately Diagnose and Stage COPD With Inspiratory-Only Chest CT
By Elana Gotkine HealthDay Reporter
TUESDAY, Dec. 17, 2024 -- Convolutional neural network (CNN)-based chronic obstructive pulmonary disease (COPD) diagnosis and staging using single-phase computed tomography (CT) has accuracy comparable to inspiratory-expiratory CT with inclusion of clinical data, according to a study published online Dec. 12 in Radiology: Cardiothoracic Imaging.
Amanda N. Lee, from San Diego State University, and colleagues conducted a retrospective study to measure the benefit of single-phase CT, inspiratory-expiratory CT, and clinical data for CNN-based COPD staging in a retrospective study using images and measurements acquired between November 2007 and April 2011 for 8,893 participants in the COPDGene phase 1 cohort.
The researchers observed moderate to good agreement for CNN-predicted and reference standard spirometry measurements (intraclass correlation coefficient [ICC], 0.66 to 0.79), which improved with inclusion of clinical data (ICC, 0.70 to 0.85) apart from forced expiratory volume in 1 second (FEV1)/forced vital capacity in the inspiratory-phase CNN model with clinical data and FEV1 in the expiratory-phase CNN model with clinical data. Single-phase CNN accuracies for Global Initiative for Chronic Obstructive Lung Disease (GOLD) stage, within-one GOLD stage, and diagnosis (GOLD 0 versus 1 to 4) varied from 59.8 to 84.1 percent, and agreement was moderate to good (ICC, 0.68 to 0.70). Using inspiratory and expiratory images, accuracies of CNN models varied from 60.0 to 86.3 percent, with moderate to good agreement (ICC, 0.72). For both the single-phase CNNs and inspiratory-expiratory CNNs, inclusion of clinical data improved agreement (ICCs: 0.72 and 0.77 to 0.78, respectively) and accuracy (62.5 to 85.8 percent and 67.6 to 88.0 percent, respectively).
"Although inspiratory CT remains the clinical standard, our findings suggest expiratory CT may be a strong candidate for imaging-based COPD staging," the authors write.
COPDGene is supported by contributions made to an industry advisory board that includes pharmaceutical companies.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted December 2024
Read this next
Generative AI Model for Draft Radiological Reporting Improves Documentation Efficiency
THURSDAY, June 12, 2025 -- Clinical use of artificial intelligence (AI)-generated draft radiograph reports is associated with improved radiologist documentation efficiency while...
Mitochondrial Genetics Key to Metastatic Melanoma Immunotherapy Resistance
THURSDAY, June 12, 2025 -- For patients with metastatic melanoma, mitochondrial (MT) haplogroup T (HG-T) is associated with resistance to an anti-programmed cell death...
Talking Therapy Reduces Depression, Anxiety Symptoms in Stroke Survivors
THURSDAY, June 12, 2025 -- For stroke survivors, talking therapy is associated with moderate reductions in depression and large reductions in anxiety symptoms, according to a...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.